A federal court last year put the kibosh on a deal whereby Allergan transferred to the tribe the Restasis patents, which the tribe then licensed back to Allergan, asserting tribal sovereign immunity to have generic companies' challenge to the patents dismissed.
A pharmaceutical company making generic drugs that include its proprietary extended-release drug delivery technology is hoping to close a $6.5 million round by the end of the month. Ezra Innovations uses a unique drug design licensed from the University of Arkansas to improve the consistency with which a drug is released from pills over time. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.